×
For best experience we recommend to activate Javascript in your browser.
XIAP antibody (AA 1-497)
This anti-XIAP antibody is a Rabbit Polyclonal antibody detecting XIAP in WB, IHC, IF and ICC. Suitable for Human.
Quick Overview for XIAP antibody (AA 1-497) (ABIN7629852)
Target
See all XIAP Antibodies
XIAP
(X-Linked Inhibitor of Apoptosis (XIAP))
Reactivity
All reactivities for XIAP antibodies
Human
Host
All hosts for XIAP antibodies
Rabbit
Clonality
All clonalities for XIAP antibodies
Polyclonal
Conjugate
All conjugates for XIAP antibodies
This XIAP antibody is un-conjugated
Application
All applications for XIAP antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
Product Details anti-XIAP Antibody
(hide)
Binding Specificity
All epitopes for XIAP antibodies
AA 1-497
Purpose
X-linked Inhibitor Of Apoptosis Protein (XIAP) Polyclonal Antibody
Sequence
Met1~Ser497
Characteristics
The X-linked Inhibitor Of Apoptosis Protein (XIAP) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC/IF.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for XIAP
(hide)
Target
XIAP
(X-Linked Inhibitor of Apoptosis (XIAP))
Alternative Name
XIAP
Gene ID
331
UniProt
P98170
Pathways
Apoptosis , Caspase Cascade in Apoptosis , Transition Metal Ion Homeostasis
Recently viewed
(hide)
Chat with us , powered by LiveChat